Skip to main navigation Skip to search Skip to main content

SLS-002: A 2-Part Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) Administered to Adults with Major Depressive Disorder at Imminent Risk of Suicide

Project: Research

Project Details

StatusFinished
Effective start/end date10/10/22 → 12/31/23

Funding

  • Syneos Health LLC: $26,050.00